The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(4-(4-(3,4,5-trimethoxyphenyl)pyrimidin-2-yl)piperazine-1-carboxamido)phenyl sulfamate ID: ALA4528566
PubChem CID: 155544938
Max Phase: Preclinical
Molecular Formula: C24H28N6O7S
Molecular Weight: 544.59
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(-c2ccnc(N3CCN(C(=O)Nc4ccc(OS(N)(=O)=O)cc4)CC3)n2)cc(OC)c1OC
Standard InChI: InChI=1S/C24H28N6O7S/c1-34-20-14-16(15-21(35-2)22(20)36-3)19-8-9-26-23(28-19)29-10-12-30(13-11-29)24(31)27-17-4-6-18(7-5-17)37-38(25,32)33/h4-9,14-15H,10-13H2,1-3H3,(H,27,31)(H2,25,32,33)
Standard InChI Key: KKMCJFBJMANXHC-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 41 0 0 0 0 0 0 0 0999 V2000
11.8823 -21.1603 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.2991 -20.4545 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
11.4774 -20.4459 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4849 -15.9269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4837 -16.7506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1959 -17.1596 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.9097 -16.7501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9069 -15.9233 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1941 -15.5139 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6199 -17.1568 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6192 -17.9791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3235 -18.3906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0371 -17.9803 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.0378 -17.1580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3248 -16.7461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7480 -18.3946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7462 -19.2159 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.4607 -17.9834 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.1717 -18.3977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1649 -19.2174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8750 -19.6275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5888 -19.2204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5879 -18.3949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8773 -17.9844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3002 -19.6297 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.0069 -20.8643 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.7735 -17.1589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0617 -16.7480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3500 -17.1554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3489 -17.9776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0654 -18.3907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7742 -17.9769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6387 -16.7459 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.6373 -18.3907 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.0676 -19.2120 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.6397 -15.9246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9294 -17.9784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3569 -19.6226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
10 11 1 0
10 15 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
7 10 1 0
13 16 1 0
16 17 2 0
16 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
22 25 1 0
25 2 1 0
2 26 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 27 1 0
5 27 1 0
29 33 1 0
30 34 1 0
31 35 1 0
33 36 1 0
34 37 1 0
35 38 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 544.59Molecular Weight (Monoisotopic): 544.1740AlogP: 2.11#Rotatable Bonds: 8Polar Surface Area: 158.44Molecular Species: NEUTRALHBA: 10HBD: 2#RO5 Violations: 1HBA (Lipinski): 13HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 10.75CX Basic pKa: 3.67CX LogP: 2.02CX LogD: 2.02Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.43Np Likeness Score: -1.28
References 1. Moi D, Foster PA, Rimmer LG, Jaffri A, Deplano A, Balboni G, Onnis V, Potter BVL.. (2019) Synthesis and in vitro evaluation of piperazinyl-ureido sulfamates as steroid sulfatase inhibitors., 182 [PMID:31422224 ] [10.1016/j.ejmech.2019.111614 ] 2. Nocentini A,Moi D,Deplano A,Osman SM,AlOthman ZA,Balboni G,Supuran CT,Onnis V. (2020) Sulfonamide/sulfamate switch with a series of piperazinylureido derivatives: Synthesis, kinetic and in silico evaluation as carbonic anhydrase isoforms I, II, IV, and IX inhibitors., 186 [PMID:31784185 ] [10.1016/j.ejmech.2019.111896 ]